FDA Fast Track: Is Pay-for-review Too Fast?

Filed in Legal, Personal Health, Research, May 18, 2007, 2:22 pm by Mariano DiFabio

Following a topic I mentioned in the last post, I’d like to review the increasingly visible issue where approved drugs in the pharmaceutical market have come under greater scrutiny because of serious side effects of these medications. The trend seemed to start around the time Merck’s anti-inflammatory drug Vioxx was targeted because of its [...]